These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 9632608
21. Oral immunization of mice with vaccine of attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit. Yang XL, Liu WC, Yang WW, Zhong D, Liu YH, Zhang JD, Jiang JH, Li SS. Biomed Environ Sci; 2005 Dec; 18(6):411-8. PubMed ID: 16544523 [Abstract] [Full Text] [Related]
22. Salmonella typhimurium aroA, htrA, and aroD htrA mutants cause progressive infections in athymic (nu/nu) BALB/c mice. Sinha K, Mastroeni P, Harrison J, de Hormaeche RD, Hormaeche CE. Infect Immun; 1997 Apr; 65(4):1566-9. PubMed ID: 9119506 [Abstract] [Full Text] [Related]
23. Induction of SIV capsid-specific CTL and mucosal sIgA in mice immunized with a recombinant S. typhimurium aroA mutant. Valentine PJ, Meyer K, Rivera MM, Lipps C, Pauza D, Maziarz RT, So M, Heffron F. Vaccine; 1996 Feb; 14(2):138-46. PubMed ID: 8852411 [Abstract] [Full Text] [Related]
24. Kinetics of the mucosal antibody secreting cell response and evidence of specific lymphocyte migration to the lung after oral immunisation with attenuated S. enterica var. typhimurium. Allen JS, Dougan G, Strugnell RA. FEMS Immunol Med Microbiol; 2000 Apr; 27(4):275-81. PubMed ID: 10727882 [Abstract] [Full Text] [Related]
27. Invasiveness and persistence of Salmonella enteritidis, Salmonella typhimurium, and a genetically defined S. enteritidis aroA strain in young chickens. Cooper GL, Venables LM, Woodward MJ, Hormaeche CE. Infect Immun; 1994 Nov; 62(11):4739-46. PubMed ID: 7927749 [Abstract] [Full Text] [Related]
29. An aromatic amino acid auxotrophic mutant of Bordetella bronchiseptica is attenuated and immunogenic in a mouse model of infection. McArthur JD, West NP, Cole JN, Jungnitz H, Guzmán CA, Chin J, Lehrbach PR, Djordjevic SP, Walker MJ. FEMS Microbiol Lett; 2003 Apr 11; 221(1):7-16. PubMed ID: 12694904 [Abstract] [Full Text] [Related]
30. Impact of vector priming on the immunogenicity of recombinant Salmonella vaccines. Vindurampulle CJ, Attridge SR. Infect Immun; 2003 Jan 11; 71(1):287-97. PubMed ID: 12496178 [Abstract] [Full Text] [Related]
31. Evaluation of Salmonella typhimurium strains harbouring defined mutations in htrA and aroA in the murine salmonellosis model. Chatfield SN, Strahan K, Pickard D, Charles IG, Hormaeche CE, Dougan G. Microb Pathog; 1992 Feb 11; 12(2):145-51. PubMed ID: 1584006 [Abstract] [Full Text] [Related]
32. Protective immunity conferred by attenuated aroA derivatives of Pasteurella multocida B:2 strains in a mouse model of hemorrhagic septicemia. Tabatabaei M, Liu Z, Finucane A, Parton R, Coote J. Infect Immun; 2002 Jul 11; 70(7):3355-62. PubMed ID: 12065473 [Abstract] [Full Text] [Related]
38. Extracellular export of Shiga toxin B-subunit/haemolysin A (C-terminus) fusion protein expressed in Salmonella typhimurium aroA-mutant and stimulation of B-subunit specific antibody responses in mice. Su GF, Brahmbhatt HN, de Lorenzo V, Wehland J, Timmis KN. Microb Pathog; 1992 Dec 11; 13(6):465-76. PubMed ID: 1302285 [Abstract] [Full Text] [Related]
39. Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers. Hohmann EL, Oletta CA, Miller SI. Vaccine; 1996 Jan 11; 14(1):19-24. PubMed ID: 8821644 [Abstract] [Full Text] [Related]